Provided by Tiger Trade Technology Pte. Ltd.

Mineralys Therapeutics, Inc.

23.63
-0.0900-0.38%
Post-market: 24.000.3700+1.57%19:41 EDT
Volume:928.30K
Turnover:22.06M
Market Cap:2.08B
PE:-5.40
High:24.34
Open:24.01
Low:23.55
Close:23.72
52wk High:47.65
52wk Low:22.30
Shares:88.16M
Float Shares:66.03M
Volume Ratio:0.56
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3763
EPS(LYR):-2.2900
ROE:-80.88%
ROA:-46.18%
PB:3.78
PE(LYR):-10.32

Loading ...

Jul 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 10, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 22, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 09, 2024

Correspondence

Form CORRESP - Correspondence
Apr 04, 2024

Major Issues Report

Form 8-K - Current report